Jälgige meid
EE
EE

Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised

Arhiiv

✕
14 märts 2025, 13:50
Dr. Alex Schneider
684
Statins Can Help Prevent Heart Disease in People with HIV— Are We Looking at the Right Risks?

Statins Can Help Prevent Heart Disease in People with HIV— Are We Looking at the Right Risks?

Now, new findings from the REPRIEVE trial, presented at the CROI 2025 Conference, show that statins do help. The study also raises a big question: Are doctors using the right tests to find out who needs these drugs the most?
HIVCROI2025statins
13 märts 2025, 12:35
Dr. Alex Schneider
498
N6LS Antibody Brings Us Closer to Long-Acting HIV Treatment

N6LS Antibody Brings Us Closer to Long-Acting HIV Treatment

Scientists have been exploring long-acting treatments that require fewer doses, while still keeping HIV in check. One promising option is VH3810109 (N6LS), a special type of antibody that fights the virus in a new way.
HIVCROIART
13 märts 2025, 10:02
Dr. Alex Schneider
1130
New Oral Islatravir/Doravirine Regimen Shows Strong Results in Two Phase 3 Studies

New Oral Islatravir/Doravirine Regimen Shows Strong Results in Two Phase 3 Studies

The studies, conducted by Merck & Co., Inc., suggest that switching to this new combination therapy is as effective as continuing with existing treatment regimens.
HIVCROI2025ART
13 märts 2025, 08:18
Dr. Alex Schneider
804
A Game-Changer for HIV Treatment?

A Game-Changer for HIV Treatment?

A new study conducted in Africa suggests that long-acting injectable HIV treatment could be just as effective as daily pills—and might offer a new way forward in the fight against HIV.
HIVCROI2025LA
12 märts 2025, 09:05
Dr. Alex Schneider
1346
A Once-Yearly HIV Prevention Shot Could Transform PrEP Access

A Once-Yearly HIV Prevention Shot Could Transform PrEP Access

Scientists at CROI 2025 presented new research showing that a single yearly injection of lenacapavir could be just as effective as current methods — potentially revolutionizing HIV prevention.
HIVCROI2025PrEPLenacapavir
12 märts 2025, 07:46
Dr. Alex Schneider
601
A New Era in HIV Treatment: Phase 2 Study Shows Promise for Twice-Yearly Injections

A New Era in HIV Treatment: Phase 2 Study Shows Promise for Twice-Yearly Injections

For decades, people living with HIV have relied on daily oral medication to maintain viral suppression, but what if a twice-yearly injection could offer the same protection? A new Phase 2 study, presented at CROI 2025, suggests this may soon become a reality.
lenacapavirHIVCROI2025bNAbs
11 märts 2025, 16:20
Dr. Alex Schneider
544
San Francisco Rally Demands Protection for HIV Research Amid Funding Cuts

San Francisco Rally Demands Protection for HIV Research Amid Funding Cuts

Hundreds of people gathered at Yerba Buena Gardens on Monday evening for the Save Our Sciences: Rally for HIV Research, a powerful demonstration in support of life-saving HIV research programs currently at risk of losing federal funding.
HIVCROI2025
11 märts 2025, 12:34
Dr. Alex Schneider
801
RIO Study Suggests Antibodies Could Offer a Break from Daily HIV Treatment

RIO Study Suggests Antibodies Could Offer a Break from Daily HIV Treatment

The RIO study, a randomized, placebo-controlled clinical trial, found that a combination of two broadly neutralizing antibodies (bNAbs) effectively delayed viral rebound, after stopping ART, raising hopes for more flexible treatment options.
HIVCROI
11 märts 2025, 10:03
Dr. Alex Schneider
1178
CROI 2025 Begins in San Francisco: Advancing Science, Strengthening Policy, and Shaping the Future of HIV Research

CROI 2025 Begins in San Francisco: Advancing Science, Strengthening Policy, and Shaping the Future of HIV Research

The Conference on Retroviruses and Opportunistic Infections (CROI) 2025 opened today in San Francisco, bringing together leading scientists, clinicians, and public health experts to discuss the latest breakthroughs and ongoing challenges in HIV and infectious disease research.
HIVCROI2025CROI
30 november 2023
Liliya Ten
5449
Future Horizons: Life4me.plus Symposium on the Future of HIV in Cologne 2024

Future Horizons: Life4me.plus Symposium on the Future of HIV in Cologne 2024

Join us at the "Future of HIV" Symposium on January 24th in Cologne, Germany—a continuation of a series dedicated to fostering dialogue between healthcare professionals and community representatives through engaging discussions. Participation is free, and physicians can ...
hivtherapydoctorsymposium
Kasutusmugavuse parendamiseks rakendab veebileht küpsiseid.
Lehel mis tahes nuppu klõpsates nõustute küpsiste kasutamisega.